A recent study reported that ITGB3 expression is higher in older AML patients (median age, 57.8; p < 0.05), especially in those with unfavorable cytogenetics (p = 0.002), e.g., Fms-like receptor tyrosine kinase 3 (FLT3)-internal tandem duplications (ITD) [46]. This evidence concerns the gene ITGB3 and acute myeloid leukemia.